Cargando…
Platelet Reactivity and Coagulation Markers in Patients with COVID-19
INTRODUTION: COVID-19 is associated with an increased risk of thrombotic events. However, the contribution of platelet reactivity (PR) to the aetiology of the increased thrombotic risk associated with COVID-19 remains unclear. Our aim was to evaluate PR in stable patients diagnosed with COVID-19 and...
Autores principales: | Bertolin, Adriadne J., Dalçóquio, Talia F., Salsoso, Rocío, de M. Furtado, Remo H., Kalil-Filho, Roberto, Hajjar, Ludhmila A., Siciliano, Rinaldo F., Kallás, Esper G., Baracioli, Luciano M., Lima, Felipe G., Giraldez, Roberto R., Cavalheiro-Filho, Cyrillo, Vieira, Alexandra, Strunz, Célia M. C., Giugliano, Robert P., Tantry, Udaya S., Gurbel, Paul A., Nicolau, José C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176448/ https://www.ncbi.nlm.nih.gov/pubmed/34086266 http://dx.doi.org/10.1007/s12325-021-01803-w |
Ejemplares similares
-
Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease
por: Salsoso, Rocío, et al.
Publicado: (2020) -
Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction
por: Genestreti, Paulo R. Rizzo, et al.
Publicado: (2022) -
Factors associated with actively working in the very long-term following acute coronary syndrome
por: Nicolau, Jose C., et al.
Publicado: (2021) -
Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction
por: Furtado, Remo H.M., et al.
Publicado: (2022) -
Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: A Prospective Interventional Trial
por: Arantes, Flávia B. B., et al.
Publicado: (2019)